<!DOCTYPE html><html><head><title>R: Chemotherapy for Stage B/C colon cancer</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R.css" />
</head><body><div class="container"><main>

<table style="width: 100%;"><tr><td>colon</td><td style="text-align: right;">R Documentation</td></tr></table>

<h2>Chemotherapy for Stage B/C colon cancer</h2>

<h3>Description</h3>

<p>These are data from one of the first successful trials of
adjuvant chemotherapy for colon cancer. Levamisole is a low-toxicity
compound previously used to treat worm infestations in animals; 5-FU
is a moderately toxic (as these things go) chemotherapy agent. There
are two records per person, one for recurrence and one for death</p>


<h3>Usage</h3>

<pre><code class='language-R'>colon
       data(cancer, package="survival")
</code></pre>


<h3>Format</h3>


<table>
<tr>
 <td style="text-align: left;">
id:</td><td style="text-align: left;"> id</td>
</tr>
<tr>
 <td style="text-align: left;">
study:</td><td style="text-align: left;"> 1 for all patients</td>
</tr>
<tr>
 <td style="text-align: left;">
rx:</td><td style="text-align: left;"> Treatment - Obs(ervation), Lev(amisole), Lev(amisole)+5-FU</td>
</tr>
<tr>
 <td style="text-align: left;">
sex:</td><td style="text-align: left;">  1=male</td>
</tr>
<tr>
 <td style="text-align: left;">
age:</td><td style="text-align: left;"> in years</td>
</tr>
<tr>
 <td style="text-align: left;">
obstruct:</td><td style="text-align: left;"> obstruction of colon by tumour</td>
</tr>
<tr>
 <td style="text-align: left;">
perfor:</td><td style="text-align: left;"> perforation of colon</td>
</tr>
<tr>
 <td style="text-align: left;">
adhere:</td><td style="text-align: left;"> adherence to nearby organs</td>
</tr>
<tr>
 <td style="text-align: left;">
nodes:</td><td style="text-align: left;"> number of lymph nodes with detectable cancer</td>
</tr>
<tr>
 <td style="text-align: left;">
time:</td><td style="text-align: left;"> days until event or censoring</td>
</tr>
<tr>
 <td style="text-align: left;">
status:</td><td style="text-align: left;"> censoring status</td>
</tr>
<tr>
 <td style="text-align: left;">
differ:</td><td style="text-align: left;"> differentiation of tumour (1=well, 2=moderate, 3=poor)</td>
</tr>
<tr>
 <td style="text-align: left;">
extent:</td><td style="text-align: left;"> Extent of local spread (1=submucosa, 2=muscle, 3=serosa,
4=contiguous structures)</td>
</tr>
<tr>
 <td style="text-align: left;">
surg:</td><td style="text-align: left;"> time from surgery to registration (0=short, 1=long)</td>
</tr>
<tr>
 <td style="text-align: left;">
node4:</td><td style="text-align: left;"> more than 4 positive lymph nodes</td>
</tr>
<tr>
 <td style="text-align: left;">
etype:</td><td style="text-align: left;"> event type: 1=recurrence,2=death</td>
</tr>
<tr>
 <td style="text-align: left;">
</td>
</tr>

</table>


<h3>Note</h3>

<p>The study is originally described in Laurie (1989). 
The main report is found in Moertel (1990).  This data set is closest
to that of the final report in Moertel (1991).
A version of the data with less follow-up time was used in the
paper by Lin (1994).
</p>
<p>Peter Higgins has pointed out a data inconsistency, revealed by
<code>table(colon$nodes, colon$node4)</code>.  We don't know which of the
two variables is actually correct so have elected not to 'fix' it.
(Real data has warts, why not have some in the example data too?)
</p>


<h3>References</h3>

<p>JA Laurie, CG Moertel, TR Fleming, HS Wieand, JE Leigh, J Rubin,
GW McCormack, JB Gerstner, JE Krook and J Malliard.  Surgical
adjuvant therapy of large-bowel carcinoma: An evaluation of
levamisole and the combination of levamisole and fluorouracil:
The North Central Cancer Treatment Group and the Mayo Clinic.
J Clinical Oncology, 7:1447-1456, 1989.
</p>
<p>DY Lin.  Cox regression analysis of multivariate failure time data:
the marginal approach.  Statistics in Medicine, 13:2233-2247, 1994.
</p>
<p>CG Moertel, TR Fleming, JS MacDonald, 
DG Haller, JA Laurie, PJ Goodman, JS Ungerleider, 
WA Emerson, DC Tormey, JH Glick, MH Veeder and JA Maillard. 
Levamisole and fluorouracil for adjuvant therapy of 
resected colon carcinoma. New England J of Medicine, 332:352-358,
1990.
</p>
<p>CG Moertel,  TR Fleming,  JS MacDonald, DG Haller, JA Laurie, CM Tangen,
JS Ungerleider, WA Emerson, DC Tormey, JH Glick, MH Veeder and JA
Maillard, Fluorouracil plus Levamisole as an effective adjuvant
therapy after resection of stage II colon carcinoma: a final report.
Annals of Internal Med, 122:321-326, 1991.
</p>

</main>

</div>
</body></html>
